022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Banner
DataBoard Demo
Mergers & Acquisitions | 27 November 2012

Otsuka Pharma May Acquire Injectibles Biz Of Claris Lifesciences

by Charmi Gutka
Otsuka Pharma May Acquire Injectibles Biz Of Claris Lifesciences
Share on Social Media Email Facebook Twitter Linkedin
 
@Charmi

Claris Lifesciences is planning to sell its injectibles business and it is in preliminary talks with Japanese Pharma firm - Otsuka Pharma for the same.

IDFC and Barclays are the bankers to the deal, ET stated.

This news comes after the announcement by Strides Arcolabs to put up its injectable-drugs unit, Agila Specialties Private Limited for sale.

Ahmedabad based, Claris Lifesciences offers injectibles in various therapeutic segments including anesthesia, critical care, anti-infectives, renal care, infusion therapy, parenteral nutrition and oncology.

It has presence in 91 countries across Latin America, Europe, Gulf, Africa, CIS, Central Asia and Asia- Pacific. Last month, Mitsui of Japan, through its healthcare arm, was plnning to invest R250 Cr in Claris.

MakeMyTrip Makes Second Acquisition This Month: Acquires Thai Group ITC

MakeMyTrip Makes Second Acquisition This Month: Acquires Thai Group ITC

U.S listed travel portal MakeMyTrip has acquired majority stake in ITC Group, enhancing its South East Asian portfolio of offerings.

Read More...

Active.AI, Indee and Affordplan receive $500K each from Kalaari Capital

Active.AI, Indee and Affordplan receive $500K each from Kalaari Capital

Kalaari Capital Advisors P. Ltd., a venture capital firm, has invested in three startups through its Kstart accelerator program. The program was launched in February 2016 with the aim of nurturing startups by building a full-fledged system to carefully monitor their growth. Kalaari Capital invests in startups through convertible equity instruments.

Read More...
Subscribe
Enter your Email address
to receive all the news